Company profile for Bluebird Bio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At bluebird bio, we’re pushing hard on gene therapy because we believe it delivers the chance for people with severe genetic diseases and cancer to live fully, regardless of what’s written in their DNA. We’re doing the hard work because people facing these challenges deserve it. Our goal is to recode the science, the system – and even the status quo – for life. We are 800+ employees across the US & Europe who care de...
At bluebird bio, we’re pushing hard on gene therapy because we believe it delivers the chance for people with severe genetic diseases and cancer to live fully, regardless of what’s written in their DNA. We’re doing the hard work because people facing these challenges deserve it. Our goal is to recode the science, the system – and even the status quo – for life. We are 800+ employees across the US & Europe who care deeply and challenge convention to help the people who need us. We are working toward four potential product approvals by 2022 and a pipeline ready to tackle a range of severe diseases.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
60 Binney St. Cambridge, MA 02142
Telephone
Telephone
339-499-9300
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.biospace.com/business/bye-bye-bluebird-gene-therapy-biotech-emerges-from-private-buyout-with-rebrand

BIOSPACE
19 Sep 2025

https://www.pharmiweb.com/press-release/2025-09-18/bluebird-bio-rebrands-as-genetix-biotherapeutics-returning-to-its-foundational-roots

PHARMAWEB
18 Sep 2025

https://www.fiercepharma.com/pharma/fda-restricts-bluebird-bio-gene-therapy-skysona-after-blood-cancer-reports

FIERCE PHARMA
12 Aug 2025

https://www.contractpharma.com/breaking-news/bluebird-bio-bolsters-management-team-with-appointments/

CONTRACTPHARMA
01 Jul 2025

https://www.businesswire.com/news/home/20250701329208/en/bluebird-bio-Strengthens-Leadership-Team-With-New-Appointments

BUSINESSWIRE
01 Jul 2025

https://www.businesswire.com/news/home/20250602288470/en/bluebird-bio-Announces-Completion-of-Acquisition-by-Carlyle-and-SK-Capital

BUSINESSWIRE
02 Jun 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty